NPPA notified regarding the fixation of the retail price of Cefadroxil Monohydrate IP eq. to Anhydrous Cefadroxil 250 mg + Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 62.5 mg

Dec 10, 2024 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on December 06, 2024, notified regarding the fixation of the retail price of Cefadroxil Monohydrate IP eq. to Anhydrous Cefadroxil 250 mg + Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 62.5 mg.

The following has been stated namely: -

• It has fixed the rate at Rs. 9.72/- for the Composition of each uncoated dispersible tablet containing: Cefadroxil Monohydrate IP eq. to Anhydrous Cefadroxil 250 mg + Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 62.5 mg.

[Notification no. - 19(4274)/2024/DP/NPPA/DIV.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT